Dr. Steven Burrell has published a new article in Le Patient Magazine!

Lutathera® lutetium (177lu) oxodotreotide for neuroendocrine tumours: a game changer concept in cancer treatment

Steven Burrell, MD, FRCPC Head of Nuclear Medicine QEII Health Sciences Centre

"When cancer has spread within the body the 2 main pillars of treatment are drugs such as chemotherapy which are administered internally and distribute throughout the body, and radiation which delivers tumour-destroying radiation from outside the body. However there is another approach..." Read more.